Presentation GLAGOV Trial: Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound Presenter: Steven E. Nissen November 15, 2016 REGISTER for free or LOG IN to view this content Clinical Cardiology Clinical Pharma Imaging & Physiology IVUS/NIRS Presentation AHA 2016 Up Next Presentation The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I) Presenter: Michael Gibson November 15, 2016 More slides + Presentation Arterial Revascularization Trial (ART) Presenter: David P. Taggart November 15, 2016 Presentation Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial Presenter: David M Kaye November 15, 2016 We Recommend
Presentation The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I) Presenter: Michael Gibson November 15, 2016
Presentation Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial Presenter: David M Kaye November 15, 2016